Put Options

14 transactions
Quarter Operation Price Per put puts change puts Held SEC Form
Q2 2024

Aug 13, 2024

SELL
$143.31 - $247.0 $1.69 Million - $2.91 Million
-11,800 Reduced 50.86%
11,400 $2.77 Million
Q1 2024

May 09, 2024

BUY
$146.51 - $198.2 $3.4 Million - $4.6 Million
23,200 New
23,200 $3.47 Million
Q1 2022

May 11, 2022

BUY
$127.18 - $173.91 $12.9 Million - $17.7 Million
101,500 New
101,500 $16.6 Million
Q4 2021

Feb 10, 2022

SELL
$159.56 - $209.29 $1.6 Million - $2.09 Million
-10,000 Closed
0 $0
Q3 2021

Nov 12, 2021

BUY
$169.75 - $207.73 $1.44 Million - $1.77 Million
8,500 Added 566.67%
10,000 $1.89 Million
Q2 2021

Aug 12, 2021

BUY
$128.63 - $176.89 $192,945 - $265,335
1,500 New
1,500 $254,000
Q4 2020

Feb 12, 2021

SELL
$122.97 - $147.0 $270,534 - $323,400
-2,200 Closed
0 $0
Q3 2020

Nov 13, 2020

BUY
$121.19 - $165.49 $266,618 - $364,078
2,200 New
2,200 $320,000
Q2 2019

Aug 12, 2019

SELL
$65.86 - $92.79 $92,204 - $129,906
-1,400 Closed
0 $0
Q1 2019

May 10, 2019

SELL
$72.76 - $93.45 $451,112 - $579,390
-6,200 Reduced 81.58%
1,400 $131,000
Q4 2018

Feb 13, 2019

SELL
$62.67 - $88.33 $2.98 Million - $4.2 Million
-47,600 Reduced 86.23%
7,600 $554,000
Q3 2018

Nov 09, 2018

BUY
$87.52 - $122.67 $4 Million - $5.61 Million
45,700 Added 481.05%
55,200 $4.83 Million
Q1 2018

May 09, 2018

BUY
$115.92 - $148.54 $683,928 - $876,386
5,900 Added 163.89%
9,500 $1.13 Million
Q3 2017

Nov 13, 2017

BUY
$72.53 - $118.27 $261,108 - $425,772
3,600
3,600 $423,000

Others Institutions Holding ALNY

About ALNYLAM PHARMACEUTICALS, INC.


  • Ticker ALNY
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 123,028,000
  • Market Cap $34B
  • Description
  • Alnylam Pharmaceuticals, Inc., a biopharmaceutical company, focuses on discovering, developing, and commercializing novel therapeutics based on ribonucleic acid interference. The company's pipeline of investigational RNAi therapeutics focuses on genetic medicines, cardio-metabolic diseases, hepatic infectious diseases, and central nervous system...
More about ALNY
Track This Portfolio

Track Twin Tree Management, LP Portfolio

Follow Twin Tree Management, LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Twin Tree Management, LP, based on Form 13F filings with the SEC.

News

Stay updated on Twin Tree Management, LP with notifications on news.